Advertisement

Prevacid - Biotech, Pharma and Life Science Channel

20:15 EDT 21st May 2013 | BioPortfolio

Prevacid, produced by Takeda Pharmaceuticals North America, Inc netted $2.5 in sales in 2009, the 10th highest in the world.

Prevacid, the trade name for lansoprazole, is a proton pump inhibitor designed to reduce to production of acid by the stomach. It is therefore prescribed for the prevention of gastric and intestinal ulcers (if risk factors are present), erosive esophagitis and Zollinger-Ellison syndrome. It is also used to treat the above, but does not provide immediate relief from heart burn.

Source; Adapted from BioPortfolio.com and Drugs.com

Add the Prevacid News Channel to your RSS reader;

Follow the Prevacid Twitter feed;

News Articles [ 4 Associated News Articles listed on BioPortfolio]

Breckenridge Announces Approval for Lansoprazole Delayed-Release Rx Capsules

BOCA RATON, Fla., Dec. 18, 2012 /PRNewswire/ -- Breckenridge Pharmaceutical, Inc. announced today the immediate launch of Prescription Lansoprazole Delayed-Release Capsules.  The U.S. Food a...

Torax Medical Secures $30M Financing to Commercialize Pioneering Treatment for Reflux Disease

Torax Medical announced today that it has completed a $30 million Series D round of financing led by Piper Jaffray Merchant Banking. Sanderling Ventures, Thomas, McNerney & Pa...

Wockhardt launches generic version of anti-ulcer drug Prevacid®

PARSIPPANY, N.J. and MUMBAI, India, Sept. 17, 2012 /PRNewswire/ -- Pharmaceutical and biotechnology major Wockhardt has received final approval from the United States Food & Drug Administration (U...

Torax Medical Names Veteran Industry Executive to Lead Global Commercialization Effort

Torax Medical announced today that Eric Masingale has joined the company as Global Vice President of Sales and Marketing. Eric comes to Torax Medical after 18 years with Stryker C...

Events [0 Results]

None

Companies [0 Results]

None

Clinical Trials [ 12 Associated Clinical Trials listed on BioPortfolio]

Proton Pump Inhibitor Therapy for Mild to Moderate Obstructive Sleep Apnea

Obstructive Sleep Apnea (OSA) is common in modern society, affecting up to 5% of working middle-aged adults in the United States. Obesity is the number one risk factor for the development...

Prevacid vs Lifestyle Modifications for the Treatment of LPR

The purpose of this study is to evaluate changes in scores on the Reflux Finding Score and Reflux Symptom Index over a 24 week period. To enroll subjects must score at least a 13 on the Re...

Effect of Prevacid on Prostaglandin Levels in Patient With Stress Ulcer

The purpose of this study is to measure the prostaglandin levels in patients with stress ulcer and the effect of Prevacid on prostaglandin levels in patients with stress ulcer.

Study of 24-Hour Intragastric pH Profiles of Esomeprazole 40 mg and Lansoprazole 30 mg in Healthy Volunteer Subjects

This study is intended to evaluate whether intravenous (iv) esomeprazole (Nexium® ) offers better intragastric acid suppression than iv lansoprazole (Prevacid ®

Proton Pump Inhibitor Therapy and Bone Density in Premature Infants

Previous research studies have shown that there may be a connection between proton pump inhibitor therapies and hip fracture in adults(1). Proton pump inhibitor(PPI) reflux medications...

Use of Topical Budesonide in the Treatment of Eosinophilic Esophagitis

This study is designed to evaluate whether or not oral viscous budesonide is effective in treating children with Eosinophilic Esophagitis.

Dietary Control Alone Versus Dietary Control Plus Use of Proton Pump Inhibitors to Treat Pediatric Hoarseness

This study will examine whether lansoprazole (Prevacid) and dietary control versus dietary control alone will improve pediatric hoarseness symptoms.

Effect of Antireflux Therapy on the Expression of Genes in Patients With GERD

Although the symptomatic and epithelial (histologic and endoscopic) response to antireflux therapy are well known and extensively studied, little is known of the genetic events occurring i...

Lansoprazole 30 mg DR Capsule Fasting Replicate Sprinkle Study

The object of this study is to compare the relative bioavailability of lansoprazole 30 mg delayed-release capsules (manufactured by TEVA Pharmaceutical Industries, Ltd. and distributed by...

Lansoprazole 30 mg DR Capsule Fasting Study

The object of this study is to compare the relative bioavailability of lansoprazole 30 mg delayed-release capsules (manufactured by TEVA Pharmaceutical Industries, Ltd. and distributed by...

PubMed Articles [0 Results]

None

Videos

Prevacid (Lansoprazole)

A pharmacist explains how Prevacid works, why doctors prescribe this acid reflux medication, and common side effects of the drug.Watch More Health Videos at ...

Medical and Biotech [MESH] Definitions

Search BioPortfolio:
Advertisement
review and buy Prevacid market research data and corporate reports here

Channels Quicklinks

Advertisement